Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ADvance DBS-f in Patients With Mild Probable Alzheimer's Disease (ADvance)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Functional Neuromodulation Ltd
ClinicalTrials.gov Identifier:
NCT01608061
First received: May 21, 2012
Last updated: October 27, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2018
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)